We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-9.18%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$51.6B
AUM Growth
-$1.23B
Cap. Flow
+$5.12B
Cap. Flow %
9.92%
Top 10 Hldgs %
13.97%
Holding
4,098
New
839
Increased
1,320
Reduced
1,195
Closed
681

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$1.55B
2
CMCSA icon
Comcast
CMCSA
+$449M
3
SLB icon
SLB Ltd
SLB
+$298M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$281M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 12.58%
2 Energy 11.62%
3 Consumer Discretionary 8.89%
4 Financials 8.63%
5 Technology 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JRJC
3301
DELISTED
China Finance Online Co., Ltd.
JRJC
$70K ﹤0.01%
+2,026
New +$85.2K
OSBC icon
3302
Old Second Bancorp
OSBC
$1.29B
$69K ﹤0.01%
+11,127
New +$70.4K
DWSN icon
3303
Dawson Geophysical
DWSN
$106M
$68K ﹤0.01%
18,756
-52,702
-74% -$217K
DS
3304
DELISTED
Drive Shack Inc.
DS
$68K ﹤0.01%
+15,572
New +$74.4K
WG
3305
DELISTED
Willbros Group
WG
$68K ﹤0.01%
53,585
-7,853
-13% -$8.21K
NBSE
3306
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$66K ﹤0.01%
60
-204
-77% -$236K
BOCH
3307
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$66K ﹤0.01%
11,411
-11,030
-49% -$63.5K
MDLY
3308
DELISTED
Medley Management Inc
MDLY
$66K ﹤0.01%
+1,003
New +$87.6K
NTIP icon
3309
Network-1 Technologies
NTIP
$35.4M
$65K ﹤0.01%
31,109
-13,866
-31% -$30.4K
TOVX icon
3310
Theriva Biologics
TOVX
$10.8M
$65K ﹤0.01%
3
-1
-25% -$24.6K
CTSO icon
3311
Cytosorbents Corp
CTSO
$23.3M
$64K ﹤0.01%
+10,200
New +$68K
PXLW icon
3312
Pixelworks
PXLW
$40.8M
$64K ﹤0.01%
+1,467
New +$87.3K
HELI
3313
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$64K ﹤0.01%
3,534
+53
+2% +$910
STRL icon
3314
Sterling Infrastructure
STRL
$15.2B
$63K ﹤0.01%
+15,400
New +$70.2K
LTS
3315
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$63K ﹤0.01%
30,040
-195,413
-87% -$538K
BYBK
3316
DELISTED
Bay Bancorp, Inc.
BYBK
$62K ﹤0.01%
12,117
-7,347
-38% -$37.2K
GLRI
3317
DELISTED
GLORI ENERGY INC COMMON STOCK
GLRI
$62K ﹤0.01%
83,760
+4,468
+6% +$5.37K
MIND icon
3318
MIND Technology
MIND
$39M
$61K ﹤0.01%
+1,615
New +$65.5K
CVM.WS
3319
DELISTED
Cel-Sci Corp Series S
CVM.WS
$60K ﹤0.01%
300,000
NHLD
3320
DELISTED
National Holdings Corporation
NHLD
$60K ﹤0.01%
21,914
-9,853
-31% -$32.4K
REN
3321
DELISTED
Resolute Energy Corporaton
REN
$59K ﹤0.01%
30,256
-827
-3% -$2.36K
EYPT icon
3322
EyePoint Inc
EYPT
$420M
$57K ﹤0.01%
+1,552
New +$60.9K
FATE icon
3323
Fate Therapeutics
FATE
$292M
$55K ﹤0.01%
+10,313
New +$70.4K
AMD icon
3324
Advanced Micro Devices
AMD
$746B
$54K ﹤0.01%
31,156
-45,609
-59% -$85.8K
IO
3325
DELISTED
ION Geophysical Corporation
IO
$53K ﹤0.01%
9,007
-25,021
-74% -$264K

Similar funds

Israel Englander's Q3 2015 Portfolio in Review

As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.

  • Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
  • Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
  • Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
  • Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
  • Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
  • Israel Englander opened 839 new positions and closed 681 in Q3 2015.
  • Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.